340 related articles for article (PubMed ID: 27841758)
1. Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration.
Zhang L; Du J; Justus S; Hsu CW; Bonet-Ponce L; Wu WH; Tsai YT; Wu WP; Jia Y; Duong JK; Mahajan VB; Lin CS; Wang S; Hurley JB; Tsang SH
J Clin Invest; 2016 Dec; 126(12):4659-4673. PubMed ID: 27841758
[TBL] [Abstract][Full Text] [Related]
2. Mid-stage intervention achieves similar efficacy as conventional early-stage treatment using gene therapy in a pre-clinical model of retinitis pigmentosa.
Wert KJ; Sancho-Pelluz J; Tsang SH
Hum Mol Genet; 2014 Jan; 23(2):514-23. PubMed ID: 24101599
[TBL] [Abstract][Full Text] [Related]
3. Replenishment of TCA cycle intermediates provides photoreceptor resilience against neurodegeneration during progression of retinitis pigmentosa.
Rowe AA; Patel PD; Gordillo R; Wert KJ
JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34292885
[TBL] [Abstract][Full Text] [Related]
4. Potential of Small Molecule-Mediated Reprogramming of Rod Photoreceptors to Treat Retinitis Pigmentosa.
Nakamura PA; Tang S; Shimchuk AA; Ding S; Reh TA
Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6407-6415. PubMed ID: 27893103
[TBL] [Abstract][Full Text] [Related]
5. Retinitis pigmentosa: impact of different Pde6a point mutations on the disease phenotype.
Sothilingam V; Garcia Garrido M; Jiao K; Buena-Atienza E; Sahaboglu A; Trifunović D; Balendran S; Koepfli T; Mühlfriedel R; Schön C; Biel M; Heckmann A; Beck SC; Michalakis S; Wissinger B; Seeliger MW; Paquet-Durand F
Hum Mol Genet; 2015 Oct; 24(19):5486-99. PubMed ID: 26188004
[TBL] [Abstract][Full Text] [Related]
6. Late-stage rescue of visually guided behavior in the context of a significantly remodeled retinitis pigmentosa mouse model.
Kajtna J; Tsang SH; Koch SF
Cell Mol Life Sci; 2022 Feb; 79(3):148. PubMed ID: 35195763
[TBL] [Abstract][Full Text] [Related]
7. Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa.
Zhang L; Chen C; Fu J; Lilley B; Berlinicke C; Hansen B; Ding D; Wang G; Wang T; Shou D; Ye Y; Mulligan T; Emmerich K; Saxena MT; Hall KR; Sharrock AV; Brandon C; Park H; Kam TI; Dawson VL; Dawson TM; Shim JS; Hanes J; Ji H; Liu JO; Qian J; Ackerley DF; Rohrer B; Zack DJ; Mumm JS
Elife; 2021 Jun; 10():. PubMed ID: 34184634
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming towards anabolism impedes degeneration in a preclinical model of retinitis pigmentosa.
Zhang L; Justus S; Xu Y; Pluchenik T; Hsu CW; Yang J; Duong JK; Lin CS; Jia Y; Bassuk AG; Mahajan VB; Tsang SH
Hum Mol Genet; 2016 Oct; 25(19):4244-4255. PubMed ID: 27516389
[TBL] [Abstract][Full Text] [Related]
9. Genetic rescue models refute nonautonomous rod cell death in retinitis pigmentosa.
Koch SF; Duong JK; Hsu CW; Tsai YT; Lin CS; Wahl-Schott CA; Tsang SH
Proc Natl Acad Sci U S A; 2017 May; 114(20):5259-5264. PubMed ID: 28468800
[TBL] [Abstract][Full Text] [Related]
10. Antioxidants slow photoreceptor cell death in mouse models of retinitis pigmentosa.
Komeima K; Rogers BS; Campochiaro PA
J Cell Physiol; 2007 Dec; 213(3):809-15. PubMed ID: 17520694
[TBL] [Abstract][Full Text] [Related]
11. Loss of cone molecular markers in rhodopsin-mutant human retinas with retinitis pigmentosa.
John SK; Smith JE; Aguirre GD; Milam AH
Mol Vis; 2000 Nov; 6():204-15. PubMed ID: 11063754
[TBL] [Abstract][Full Text] [Related]
12. Long-term preservation of cone photoreceptors and visual acuity in rd10 mutant mice exposed to continuous environmental enrichment.
Barone I; Novelli E; Strettoi E
Mol Vis; 2014; 20():1545-56. PubMed ID: 25489227
[TBL] [Abstract][Full Text] [Related]
13. Different effects of valproic acid on photoreceptor loss in Rd1 and Rd10 retinal degeneration mice.
Mitton KP; Guzman AE; Deshpande M; Byrd D; DeLooff C; Mkoyan K; Zlojutro P; Wallace A; Metcalf B; Laux K; Sotzen J; Tran T
Mol Vis; 2014; 20():1527-44. PubMed ID: 25489226
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy provides long-term visual function in a pre-clinical model of retinitis pigmentosa.
Wert KJ; Davis RJ; Sancho-Pelluz J; Nishina PM; Tsang SH
Hum Mol Genet; 2013 Feb; 22(3):558-67. PubMed ID: 23108158
[TBL] [Abstract][Full Text] [Related]
15. Knockout of Ca
Kilicarslan I; Zanetti L; Novelli E; Schwarzer C; Strettoi E; Koschak A
Sci Rep; 2021 Jul; 11(1):15146. PubMed ID: 34312410
[TBL] [Abstract][Full Text] [Related]
16. How Excessive cGMP Impacts Metabolic Proteins in Retinas at the Onset of Degeneration.
Du J; An J; Linton JD; Wang Y; Hurley JB
Adv Exp Med Biol; 2018; 1074():289-295. PubMed ID: 29721955
[TBL] [Abstract][Full Text] [Related]
17. The PDE6 mutation in the rd10 retinal degeneration mouse model causes protein mislocalization and instability and promotes cell death through increased ion influx.
Wang T; Reingruber J; Woodruff ML; Majumder A; Camarena A; Artemyev NO; Fain GL; Chen J
J Biol Chem; 2018 Oct; 293(40):15332-15346. PubMed ID: 30126843
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy in the rd6 mouse model of retinal degeneration.
Dinculescu A; Min SH; Deng WT; Li Q; Hauswirth WW
Adv Exp Med Biol; 2014; 801():711-8. PubMed ID: 24664762
[TBL] [Abstract][Full Text] [Related]
19. Targeted ablation of the Pde6h gene in mice reveals cross-species differences in cone and rod phototransduction protein isoform inventory.
Brennenstuhl C; Tanimoto N; Burkard M; Wagner R; Bolz S; Trifunovic D; Kabagema-Bilan C; Paquet-Durand F; Beck SC; Huber G; Seeliger MW; Ruth P; Wissinger B; Lukowski R
J Biol Chem; 2015 Apr; 290(16):10242-55. PubMed ID: 25739440
[TBL] [Abstract][Full Text] [Related]
20. CRISPR editing of anti-anemia drug target rescues independent preclinical models of retinitis pigmentosa.
Nolan ND; Cui X; Robbings BM; Demirkol A; Pandey K; Wu WH; Hu HF; Jenny LA; Lin CS; Hass DT; Du J; Hurley JB; Tsang SH
Cell Rep Med; 2024 Apr; 5(4):101459. PubMed ID: 38518771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
